Stockscreener 앱 받기
205.08
0.31%
0.63
시간 외 거래:
205.08
Becton Dickinson Co 주식(BDX)의 최신 뉴스
Forecasting The Future: 4 Analyst Projections For Becton Dickinson - Benzinga
Piper Sandler cuts Becton Dickinson target to $260 By Investing.com - Investing.com Nigeria
Piper Sandler Adjusts Price Target on Becton, Dickinson and Company to $260 From $280 - marketscreener.com
Piper Sandler cuts Becton Dickinson target to $260 - Investing.com
BD launches bioabsorbable mesh for hernia repair following FDA nod - MassDevice
Becton, Dickinson and Co Launches Umbilical Hernia Patch After FDA Clearance - marketscreener.com
BD introduces first fully absorbable hernia patch - Investing.com
BD Launches Industry-First Bioabsorbable Mesh Designed for Umbilical Hernia Repair - marketscreener.com
BD introduces first fully absorbable hernia patch By Investing.com - Investing.com UK
High Content Screening and Imaging Market Set for 8.4% CAGR Through 2029 - GlobeNewswire Inc.
BD Stock Down Despite Monitoring Platform Launch to Boost Patient Care - Yahoo Finance
Becton, Dickinson and Company’s Quarterly Earnings Preview: What You Need to Know - MSN
BD Launches Next Generation Hemodynamic Monitoring Solution Providing Clinicians with AI-Driven Clinical Decision Support - marketscreener.com
Becton, Dickinson and Company Launches Next Generation Hemodynamic Monitoring Solution Providing Clinicians with Ai-Driven Clinical Decision Support - marketscreener.com
BD warns on intravascular catheter - MassDevice
Is Becton, Dickinson and Company (BDX) the Best Dividend Monarch to Invest in Now? - Insider Monkey
Is Becton Dickinson Gaining or Losing Market Support? - Benzinga
As historic trial starts in Covington, medical devoce sterilizer defends ‘safe and responsible’ operations - AJC.com
Becton, Dickinson and Co. : Leading Industry Analyst Amit Bhalla Joins BD as Vice President, Global Strategy and Development - marketscreener.com
Becton Dickinson in talks with Thermo Fisher, Danaher to divest life sciences unit, FT reports - MSN
Barclays Has Lowered Expectations for Becton, Dickinson and Company (NYSE:BDX) Stock Price - MarketBeat
Retired truck driver contends emissions from ethylene oxide caused his cancer - AJC.com
BD to acquire Bard - The Covington News
Becton, Dickinson and Co. : BD Appoints Christopher Reidy as Chief Financial Officer - marketscreener.com
Becton Dickinson EVP Michael Garrison sells $94,497 in stock - Investing.com Australia
Becton Dickinson EVP Michael Garrison sells $94,497 in stock By Investing.com - Investing.com Canada
Becton Dickinson and : BD Receives FDA 510(k) Clearance for Advanced Microbiology Solution - marketscreener.com
Becton Dickinson's SWOT analysis: med tech giant's stock poised for growth - Investing.com
BD Seeks Potential Buyers for Life Sciences Business Division - Yahoo Finance
Citigroup Adjusts Becton Dickinson and Co. Price Target to $270 From $275, Maintains Buy Rating - MarketScreener
Becton, Dickinson Becomes Oversold - Nasdaq
Should You be Confident in Becton, Dickinson and Company’s (BDX) Ability to Deliver Long-Term Returns? - Yahoo
BD reports pay increases for some execs, decreases for others - Medical Design & Outsourcing
Becton Dickinson & Co (BDX) Shares Down 5.7% on Apr 4 - GuruFocus
BD to Announce Financial Results for its Second Quarter of Fiscal 2025 - Quantisnow
Vascular Access Device Market Growth is Driven by Ongoing Research and Development in the Industry, Key Players -Becton, Dickinson and Company, - Global Banking | Finance | Review
Report: BD is in talks with competitors to sell Life Sciences biz - MassDevice
Becton Dickinson in talks with Thermo Fisher, Danaher to divest life sciences unit, FT reports - MarketScreener
Becton Dickinson in talks to divest life sciences unit, FT reports - MarketScreener
Becton Dickinson In Talks With Rivals Over Divesting Life Sciences Unit- FT - marketscreener.com
Becton Dickinson in talks with rivals over divesting life sciences unit - Financial Times
BD Named One of America's Most Innovative Companies by Fortune - Quantisnow
Becton Dickinson Could Be Cure To Demand For Medtech Supplies, With Robust Pipeline - Seeking Alpha
Here’s What Positions Becton, Dickinson and Company (BDX) Favorably in the Health Care Sector - Yahoo Finance
BD Names Gregory J. Hayes to Board of Directors :: Becton, Dickinson and Company (BDX) - Becton Dickinson
BD Names Gregory J. Hayes to Board of Directors - Quantisnow
BD Names Gregory J. Hayes to Board of Directors – Company Announcement - Financial Times
Goldman Sachs Adjusts PT on Becton Dickinson and Co. to $256 From $253, Keeps Buy Rating - Marketscreener.com
Goldman Sachs Adjusts PT to Becton Dickinson and Co. to $256 From $253, Keeps Buy Rating - marketscreener.com
BDX Stock Declines Following Class I Classification for Alaris Recall - Yahoo Finance
0.27%
0.09%
자본화:
|
볼륨(24시간):